Multicenter clinical study of Yiqi tongluo decoction in prevention and treatment of restenosis after stenting in patients with acute coronary syndrome
- Conditions
- acute coronary syndrome
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) All patients were clinically diagnosed with acute coronary syndrome, including unstable angina, ST-elevation myocardial infarction and non-ST-elevation myocardial infarction, followed by coronary intervention with at least one stent;
(2) Within one month of Stenting, age 40-80 years old, sex is not limited;
(3) The Syndrome of Qi deficiency and blood stasis;
(4) The patient and the family are willing to cooperate and meet the exclusion criteria.
(1) Patients with cardiac function grade 4 or Pulmonary Edema;
(2) Patients with severe primary brain, lung disease and hepatic and renal dysfunction;
(3) Patients with allergic reaction to traditional Chinese medicine;
(4) Patients with malignant disease;
(5) Patients with severe inflammatory disease;
(6) Patients with hemorrhagic disease;
(7) Patients with Malignant Arrhythmia;
(8) Mentally ill;
(9) Pregnant or lactating women;
(10) Enrolled in its clinical trial within 1 month.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method stent restenosis;
- Secondary Outcome Measures
Name Time Method Evaluation of therapeutic effect of angina pectoris symptoms;Evaluation of TCM syndrome curative effect;SAQ;Cardiovascular events;